Mkts

Moderna, Inc.

NASDAQ: MRNA
$228.44+7.61 (+3.45%)
As of Nov 3, 4:00 PM ET

Key statistics

Day range
220.23235.50
52-week range
22.28254.48
Today
Open222.01
Previous close228.44
Volume—
Valuation
Market cap91.27B
P/E ratio—
EPS (TTM)-7.98
Income & risk
Dividend / yield—
Beta1.25
Avg volume17.25M
Discussion

MRNA News

Stories mentioning MRNA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue389,000678,0001,016,000142,000108,000966,0001,862,000241,000
Cost of Goods Sold955,000452,000207,000119,00090,000739,000514,000115,000
Gross Profit(566,000)226,000809,00023,00018,000227,0001,348,000126,000
Operating Expenses
Research & Development649,000775,000801,000700,000856,0001,122,0001,137,0001,221,000
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(1,388,000)(857,000)(260,000)(907,000)(1,050,000)(1,246,000)(70,000)(1,363,000)
Interest Income72,00070,00073,00081,00090,00091,000103,000111,000
Interest Expense
Other Expense(18,000)(12,000)0.008,000(4,000)(29,000)(12,000)(27,000)
Pretax Income(1,334,000)(799,000)(187,000)(818,000)(964,000)(1,184,000)21,000(1,279,000)
Tax Provision9,00027,00013,0007,0007,000(64,000)8,0000.00
Net Income (Loss)(1,343,000)(826,000)(200,000)(825,000)(971,000)(1,120,000)13,000(1,279,000)
Earnings Per Share (Basic)(3.40)(2.12)(0.51)(2.13)(2.52)(2.92)0.03(3.33)
Earnings Per Share (Diluted)(3.40)(2.12)(0.51)(2.13)(2.52)(2.92)0.03(3.33)
Weighted Average Shares Outstanding (Basic)395,000389,000390,000388,000386,000384,000385,000384,000
Weighted Average Shares Outstanding (Diluted)395,000389,000390,000388,000386,000384,000399,000384,000

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MRNA

Moderna, Inc. (NASDAQ: MRNA) is a stock listed on the Nasdaq Stock Market under the ticker symbol MRNA. It last traded at $228.44 (Nov 3, 2026, 4:00 PM ET), up 3.5% on the day. That gives Moderna a market capitalisation of $91.3B.

Over the past 52 weeks MRNA has traded between $22.28 and $254.48.

Revenue for the quarter ended Mar 31, 2026 was $389.0M; a net loss of $1.3B. Revenue was up 260% from $108.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$389.0M-$1.3B-345.2%
Dec 31, 2025$678.0M-$826.0M-121.8%
Sep 30, 2025$1.0B-$200.0M-19.7%
Jun 30, 2025$142.0M-$825.0M-581.0%

From Moderna’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…